3rd Quarter - Report

THE SMITH-FREE GROUP, LLC for GVB BIOPHARMA

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Discussions relating to regulation of the CBD industry. Discussions relating to Farm Bill Reauthorization. Discussions relating to regulation of Delta-8 THC. Monitored H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act. Monitored S. 910 Secure and Fair Enforcement (SAFE) Banking Act. Monitored executive branch nominations to federal agencies and commissions.

LobbyistCovered position, as disclosed
JOHN CHRISTIE —
JACK S DEUSER —
MICHAEL A. GAFFIN —
TREVOR W. KOLEGO —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: S. 910 (117th), S. 253 (117th), H.R. 841 (117th)

Law Enforcement/Crime/Criminal Justice LAW

Monitored H.R. 6129, HOPE Act of 2021 Monitored H.R. 3617, MORE Act of 2021

LobbyistCovered position, as disclosed
TREVOR W. KOLEGO —

Bills named: H.R. 6129 (117th), H.R. 3617 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.